Cancer incidence and mortality in the Bucaramanga metropolitan area, 2003-2007

Claudia Janeth Uribe; Sonia Osma; Victor Herrera

doi:10.25100/cm.v43i4.1196

##plugins.block.makeSubmission.linkLabel##

Cancer incidence and mortality in the Bucaramanga metropolitan area, 2003-2007

https://doi.org/10.25100/cm.v43i4.1196

Cáncer incidencia mortalidad CIE-O-3 registros poblacionales de cáncer Bucaramanga

PDF HTML

Published: Dec 29, 2012

Issue: Vol. 43 No. 4 (2012): Numbers in cancer: 50-year of The Population-based Cancer Registry of Cali

Section Original Articles

Publcation metrics

521 | 418 | 133

Authors

Claudia Janeth Uribe

Sonia Osma +

Victor Herrera

Abstract

Introduction: Cancer is an important cause of morbidity and mortality worldwide. Population-based cancer registries (PBCRs) make possible to estimate the burden of this condition.

Objetive: To estimate cancer incidence and mortality rates in the Bucaramanga Metropolitan Area (BMA) during 2003-2007.

Methods: Incident cases of invasive cancer diagnosed during 2003-2007 were identified from the Bucaramanga Metropolitan Area PBCR (BMA-PBCR). Population counts and mortality were obtained from the Colombian National Administrative Department of Statistics (NADS). We estimated total and cancer-specific crude incidence and mortality rates by age group and sex, as well as age-standardized (Segi’s world population) incidence (ASIR[W]) and mortality (ASMR[W]) rates. Statistical analyses were conducted using CanReg4 and Stata/IC 10.1.

Results: We identified 8,225 new cases of cancer excluding non-melanoma skin cancer (54.3% among women). Of all cases, 6,943 (84.4%) were verified by microscopy and 669 (8.1%) were detected only by death certificate. ASIR(W) for all invasive cancers was 162.8 per 100,000 women and 177.6 per 100,000 men. Breast, cervix, colorectal, stomach and thyroid were the most common types of cancer in women. In men, the corresponding malignancies were prostate, stomach, colorectal, lung and lymphoma. ASMR(W) was 84.5 per 100,000 person-years in women and 106.2 per 100,000 person-years in men. Breast and stomach cancer ranked first as causes of death in those groups, respectively.

Conclusion: Overall, mortality rates in our region are higher than national estimates possibly due to limited effectiveness of secondary prevention strategies. Our work emphasizes the importance of maintaining high-quality, nationwide PBCRs.

How to Cite

Uribe, C. J., Osma, S., & Herrera, V. (2012). Cancer incidence and mortality in the Bucaramanga metropolitan area, 2003-2007. Colombia Medica, 43(4), 290–297. https://doi.org/10.25100/cm.v43i4.1196

References

1. World Health Organization [Internet]. World cancer fact sheet N° 297. February 2012. [cited 2012 Nov 06]. Available from: http://www.who.int/mediacentre/factsheets/fs297/en/. Geneva: WHO; 2012.

2. Ferlay J, Shin H, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010; 127(12): 2893-917.

3. Ministerio de la Protección Social. Plan nacional para el control del cáncer en Colombia 2010-2019. Bogotá: Instituto Nacional de Cancerología-ESE, Ministerio de la Protección Social; 2010.

4. Parkin D. The role of cancer registries in cancer control. Int J Clin Oncol. 2008; 13: 102-11.

5. Área Metropolitana de Bucaramanga, Colombia. [Internet]. Área Metropolitana de Bucaramanga - Jurisdicción. [cited 2012 Jun 26] http://www.amb.gov.co Bucaramanga: Área Metropolitana de Bucaramanga; 2012

6. DANE. Censo general 2005. [Internet]. Series de Población 1985-2020. [cited 2011 Oct 13] . Available from: http://www.dane.gov.co Bogotá: DANE; 2005.

7. Observatorio de Salud Pública de Santander. [Internet]. Indicadores básicos 2011. [cited 2012 Jun 15]. Available from: http://www.saludsantander.gov.co Observatorio de Salud Pública de Santander; 2011

8. Jensen O, Parkin D, MacLennan R, Muir C, Skeet R, editors. Cancer registration: principles and methods. Scientific Publication N° 95. Lyon: IARC; 1991.

9. Piñeros M, Murillo R. Incidencia de cáncer en Colombia: importancia de las fuentes de información en la obtención de cifras estimativas. Rev Colomb Cancerol. 2004; 8 (1): 5-14.

10. OPS. Clasificación Internacional de Enfermedades para Oncología. 3ª ed. Washington, DC: Organización Panamericana de la Salud/Organización Mundial de la Salud; 2003.

11. IARC, WHO,ENRC. [Internet]. International rules for multiple primaries. ICD-O 3rded. Internal Report N° 2004/02. [cited 2011 Jun 01]. Available from: http://www.iacr.com.fr/MPrules_july2004.pdf. Lyon: IARC; 2004.

12. IARC [Internet]. Software IARC-crg Tools v 2.05. [cited 2011 Jun 01]. Available from: http://www.iacr.com.fr/iarccrgtools.htm. Lyon: IARC; 2008.

13. CDC, NPCR. [Internet]. Registry Plus TM Link Plus. Software and Tools. [cited 2011 Jun 01]. Available from: http://www.cdc.gov/cancer Atlanta: National Program of Cancer Registries (NPCR), Center for Disease Control and Prevention; 2007.

14. Cendales R, Pardo C, Uribe C, López G, Yépez M, Bravo L. Data quality at population-based cancer registries in Colombia. Biomédica. 2012; 32 (4): 536-44.

15. Hofferkamp J. [Internet]. Standards for completeness, quality, analysis, management, security and confidentiality of data. In: Hofferkamp J, editor. Standards for cancer registries. Vol. III. [cited 2011 Nov 26]. Available from: http://www.naaccr.org North American Association of Central Cancer Registries; 2008; 179 p.

16. Shin H, Curado M, Ferlay J, Heanue M, Edwards B, Storm H. Comparability and quality of data. In: Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M, editors. Cancer Incidence in five continents. Vol. IX. Lyon: International Agency for Research on Cancer, International Association of Cancer Registries; 2007. 896 p.

17. Pardo C, Cendales R. Incidencia estimada y mortalidad por cáncer en Colombia, 2002-2006. Bogotá: Ministerio de la Protección Social, Instituto Nacional de Cancerología; 2010.

18. Universidad del Valle. [Internet]. Resumen de incidencia y mortalidad. [cited 2012 Aug 27]. Available from: http://rpcc.univalle.edu.co/ Registro Poblacional de Cáncer de Cali; 2012.

19. Curado M, Edwards B, Shin H, Storn H, Ferlay J, Heanue M, et al. Cancer incidence in five continents. Vol IX. Lyon: IARC Press; 2007.

20. Curado M. Breast cancer in the world: incidence and mortality. Salud Publica Mex. 2011; 53: 372-84.

21. Bantis A, Vasiliou O. Prostate cancer incidence, mortality, total and free prostate specific antigen. Hell J Nucl Med. 2009; 12 (2): 106-9.

22. Piñeros M, Pardo C, Gamboa Ó, Hernández G. Atlas de mortalidad por cáncer en Colombia. Bogotá: Instituto Nacional de Cancerología-ESE, Instituto Geográfico Agustín Codazzi; 2010.

23. Benson J, Jatoi I. The global breast cancer burden. Future Oncol. 2012; 8 (6): 697-702.

24. Sloan FA, Gelband H, editors. Cancer control opportunities in low- and middle-income countries. The cancer burden in low- and middle-income countries and how it is measured. Washington, DC: National Academies Press; 2007.

Usage statistics